Company Profile: Center for Business Models in Healthcare

Abstract

The Center for Business Models in Healthcare (CBM-HC; IL, USA) is an independent investigator firm conducting health services research and facilitating collaborative interventions focused on personalized medicine and personalized healthcare. CBM-HC‘s objective is to encourage the adoption of personalized medicine in care delivery and reimbursement. CBM-HC‘s work focuses primarily on oncology, but also includes autoimmune, cardiovascular and other diseases. CBM-HC conducts studies of barriers to adoption of personalized medicine in care delivery and reimbursement, and facilitates development and implementation of solutions to these barriers in the form of care delivery interventions, and new models of coverage and reimbursement. This work is conducted using the 4R Framework^© developed by CBM-HC – Right Information and Right Care to the Right Patient at the Right Time. The framework allows the examination and addressing of complex interdependent barriers to personalized medicine arising from care delivery and reimbursement. CBM-HC conducts its work in collaboration with several noted academic centers and via its network of other stakeholders, including health systems, patient advocates, payers and product developers.

Financial & competing interests disclosure

JR Trosman and CB Weldon are co-founders and co-directors of the Center for Business Models in Healthcare. They received consulting fees from Abbott Laboratories, Genentech, Myriad Genetics, Life Technologies, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, and Novartis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.